Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity-Reference-Cited by-同舟云学术

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity

Published:2016-12-25 Issue:5 Volume:8 Page:8383-8396
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mazzucchelli Serena¹,Bellini Michela²,Fiandra Luisa¹,Truffi Marta¹,Rizzuto Maria A.²,Sorrentino Luca¹,Longhi Erika¹,Nebuloni Manuela¹,Prosperi Davide²,Corsi Fabio¹³

Affiliation:

1. Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, Milan, Italy

2. Department of Biotechnology and Biosciences, University of Milan-Bicocca, Milano, Italy

3. Surgery Department, Breast Unit, ICS Maugeri S. p. A. SB, Pavia, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy;Journal of Nanobiotechnology;2024-04-15

2. Deciphering the Role of H-Ferritin Nanocages in Improving Tumor-Targeted Delivery of Indocyanine Green: Combined Analysis of Murine Tissue Homogenates with UHPLC–MS/MS and Fluorescence;ACS Omega;2023-12-11

3. Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis;Pharmacological Research;2023-10

4. Co-Encapsulation of Hydrophilic and Hydrophobic Drugs into Human H Chain Ferritin Nanocarrier Enhances Antitumor Efficacy;ACS Biomaterials Science & Engineering;2023-04-18

5. A Metal‐Polyphenol‐Based Oxygen Economizer and Fenton Reaction Amplifier for Self‐Enhanced Synergistic Photothermal/Chemodynamic/Chemotherapy;Advanced Healthcare Materials;2023-04-12